Pregled bibliografske jedinice broj: 884967
Remission and employment status in schizophrenia and other psychoses : One-year prospective study in Croatian patients treated with risperidone long acting injection
Remission and employment status in schizophrenia and other psychoses : One-year prospective study in Croatian patients treated with risperidone long acting injection // Psychiatria Danubina, 28 (2016), 3; 263-272 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 884967 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Remission and employment status in schizophrenia
and other psychoses : One-year prospective study
in Croatian patients treated with risperidone long
acting injection
Autori
Mihaljević-Peleš, Alma ; Šagud, Marina ; Filipčić Šimunović, Ivona ; Grošić, Vladimir ; Pedišić, Ivana ; Emsley, Robin
Izvornik
Psychiatria Danubina (0353-5053) 28
(2016), 3;
263-272
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
schizophrenia ; risperidone long-acting injectable (RLAI) ; non-adherence ; remission ; employment in schizophrenia
Sažetak
While numerous studies have confirmed the efficacy of risperidone long-acting injectable (RLAI) on many clinical outcomes in patients with schizophrenia, there is no data regarding its influence on employment status. This was a 12- month observational study with flexible doses of RLAI on a Croatian population of patients with schizophrenia and other psychoses. Visits were at baseline and after 1, 3, 6 and 12 months of treatment. Treatment response was evaluated using Clinical Global Impression of Illness Severity (CGI-S) and Improvement (CGI-I) scales, while remission was defined by 8 items of Positive and Negative Syndrome Scale (PANSS). Employment status was determined at baseline and at study endpoint. A total of 362 patients were included, with a median age of 37 (interquartile range 29-47) years, 63.5 % were males and 67.4% were hospitalised at baseline. Overall 258 (71.3%) patients completed the study. Improvements in CGI- S scores from baseline were significant (p<0.001) at all visits. Remission criteria were met in 9 (2.5%) patients at baseline, and in 199 (54.9%) at endpoint, while 144 patients (52.7%) achieved symptomatic remission. Female patients were five times more likely to achieve symptomatic remission (OR=5.2 ; 95%CI=2.64-10.19). At baseline, 74/362 (20.4%) patients were employed, compared to 77/257 (30.0%) at endpoint (p<0.001). Adverse events were spontaneously reported in 55 (15.2%) patients. Three patients died (judged not to be related to RLAI) and one patient committed homicide. Patients treated with RLAI had significant improvements in CGI-S scale scores, hospitalization status, rates of remission and employment status, indicating the benefits of continuous treatment over time. Further studies on the comparative impact of different treatment strategies on functional recovery are needed.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Opća bolnica Šibenik,
Klinički bolnički centar Zagreb,
Psihijatrijska bolnica "Sveti Ivan" Zagreb
Profili:
IVONA ŠIMUNOVIĆ FILIPČIĆ
(autor)
Alma Mihaljević-Peleš
(autor)
Vladimir Grošić
(autor)
Marina Šagud
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- Social Science Citation Index (SSCI)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE